Skip to main content

nl
fr
en
de

Other official information and services: www.belgium.be

Your medicine and health products

About the FAMHP
Jobs
Publications
Press
Contact
Complaints
Webportal

Home
Human use
Veterinary use
Information for the public
Information for professionals

Home
Veterinary use
Medicines
Medicines
Marketing Authorisation procedures
MRL

Medicines
- Medicines
Particular products
Health products
- Distribution

Maximum residue limits (MRL)

Under construction.

Last updated on 30/12/2008

Notification of adverse reactions or incidents

PIL and SPC
of a medicine

(PIL: patient information leaflet SPC: summary of product characteristics)

News

19/10/2020

Coronavirus: Belgium agrees on procurement of Janssen's (Johnson & Johnson) vaccine candidate

19/10/2020

Influenza vaccine: one million doses are still expected and will be distributed to pharmacies between late October and early November

14/10/2020

Influenza vaccine: 10% of the stocks already distributed to the patients, two thirds still to be distributed to (hospital) pharmacies

08/10/2020

Influenza vaccine: People aged 50 years and over can get the vaccine in pharmacies without prescription

All news

© 2016 - FAMHP

Site map
Disclaimer